skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

In this informative panel discussion, driven by data from Medtrack, analysts and executives from Strategic Transactions, Trialtrove and Medtrack explored current deal-making activity, financial trends, deal values, upfronts, milestones, and royalties, as well as a view of the current landscape in oncology therapies, partnering, and clinical trials, including combinations in immune-oncology trials.


Global Transactions in Pharma/Biotech from Pharma Intelligence


  • Trialtrove: 医療用医薬品の臨床試験情報データベース, Sitetrove: 治験責任医師と治験施設情報のデー...

    Informa Pharma Intelligence Launches Free COVID-19 Content Hub

    Hub Will Include Free Content Updated Daily Including Comprehensive Data on Clinical Trials, Pipeline, Market Events and Insights 

    Topics Coronavirus

  • Strategic Transactions

    2019 IPOs Startup Firms Grab Nearly One-Third Of Total Proceeds

    Last year, a total of 67 biopharma and medtech companies completed initial public offerings (IPOs), raising for $8.55bn combined.

    Topics Drug Pricing

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Trialtrove: 医療用医薬品の臨床試験情報デ...

    COVID-19 Infographic

    Access the infographic below which explores the number of treatment drugs for COVID-19 currently in clinical trials or in development, events including progress updates, partnerships, regulatory and trial announcements etc, and the number of articles published on COVID-19 as of March 3, 2020. This data has been tracked and reported via Informa Pharma Intelligence’s clinical, regulatory and commercial data and analytics, and news and insight tools including Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet, Medtech Insight, and Generics Bulletin etc.

    Topics Coronavirus






電話:+81 (0)3 6273 4260